ImmunityBio, Inc.
DE ˙ DB ˙ US45256X1037
6,33 € ↑0,20 (3,26%)
2026-06-04
DEL PRIS
SecurityDE:26CA / ImmunityBio, Inc.
InstitutionDaiwa Securities Group Inc.
Latest Disclosed Ownership199,200 shares
Latest Disclosed Value $ 1,527,864
Daiwa Securities Group Inc. ownership in 26CA / ImmunityBio, Inc.

On May 13, 2026 - Daiwa Securities Group Inc. filed a 13F-HR form disclosing ownership of 199,200 shares of ImmunityBio, Inc. (DE:26CA) valued at $1,306,752 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 3,173 shares of ImmunityBio, Inc.. The current value of the position is $1,260,936 USD.

Daiwa Securities Group Inc. has a history of taking positions in derivatives of the underlying security (26CA) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:26CA / ImmunityBio, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F IMMUNITYBIO COM 45256X103 199,200 196,027 6,177.97 1,528 0.0044
2026-02-10 2025-12-31 13F IMMUNITYBIO COM 45256X103 3,173 0 0.00 0 0.0000
2025-11-14 2025-09-30 13F IMMUNITYBIO COM 45256X103 3,173 0 0.00 0 0.0000
2025-08-14 2025-06-30 13F IMMUNITYBIO COM 45256X103 3,173 553 21.11 0 0.0000
2025-05-13 2025-03-31 13F IMMUNITYBIO COM 45256X103 2,620 0 0.00 0 0.0000
2025-02-07 2024-12-31 13F IMMUNITYBIO COM 45256X103 2,620 0 0.00 0 0.0000
2024-11-12 2024-09-30 13F IMMUNITYBIO COM 45256X103 2,620 0 0.00 0 0.0000
2024-08-07 2024-06-30 13F IMMUNITYBIO COM 45256X103 2,620 -110 -4.03 0 0.0001
2024-05-02 2024-03-31 13F IMMUNITYBIO COM 45256X103 2,730 0 0.00 0 0.0001
2024-01-31 2023-12-31 13F IMMUNITYBIO COM 45256X103 2,730 1,120 69.57 0 0.0001
2023-11-01 2023-09-30 13F IMMUNITYBIO COM 45256X103 1,610 0 0.00 0 0.0000
2023-07-31 2023-06-30 13F IMMUNITYBIO COM 45256X103 1,610 0 0.00 0 0.0000
2023-05-02 2023-03-31 13F IMMUNITYBIO COM 45256X103 1,610 0 0.00 0 0.0000
2023-02-06 2022-12-31 13F IMMUNITYBIO COM 45256X103 1,610 127 8.56 0 -100.00 0.0001
2022-11-02 2022-09-30 13F IMMUNITYBIO COM 45256X103 1,483 -24,106 -94.20 7 -92.63 0.0001
2022-08-09 2022-06-30 13F IMMUNITYBIO COM 45256X103 25,589 3,157 14.07 95 -24.60 0.0007
2022-04-29 2022-03-31 13F IMMUNITYBIO COM 45256X103 22,432 6,676 42.37 126 31.25 0.0006
2022-02-03 2021-12-31 13F IMMUNITYBIO COM 45256X103 15,756 9,936 170.72 96 68.42 0.0006
2021-11-05 2021-09-30 13F IMMUNITYBIO COM 45256X103 5,820 5,074 680.16 57 418.18 0.0004
2021-08-06 2021-06-30 13F IMMUNITYBIO COM 45256X103 746 530 245.37 11 120.00 0.0001
2021-05-03 2021-03-31 13F IMMUNITYBIO COM 45256X103 216 12 5.88 5 66.67 0.0000
2021-02-04 2020-12-31 13F NANTKWEST COM 63016Q102 204 204 3 0.0000
2019-02-05 2018-12-31 13F NANTKWEST COM 63016Q102 0 -439 -100.00 0 -100.00
2018-11-01 2018-09-30 13F NANTKWEST COM 63016Q102 439 0 0.00 2 100.00 0.0000
2018-07-30 2018-06-30 13F NANTKWEST COM 63016Q102 439 0 0.00 1 -50.00 0.0000
2018-05-02 2018-03-31 13F NANTKWEST COM 63016Q102 439 439 2 0.0000
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F IMMUNITYBIO COM Put 199,200 464 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.